By vgreene, 2 June, 2017 Spermicide nbsp nbsp High risk for HIV as repeated and high dose use of spermicide nonoxynol 9 is assoc w uarr risk for genital lesions which may uarr HIV infection risk 4 But vaginal pH modulator safe for use 1 nbsp nbsp HIV as spermicide use may disrupt
By vgreene, 2 June, 2017 Diaphragm nbsp nbsp Unsuitable anatomy post partum until uterine involution complete 6wk after 2nd trimester ab if cervical prolapse diaphragm if distorted cervical anatomy cap nbsp nbsp High risk for HIV as repeated and high dose use of spermicide nonoxy
By vgreene, 2 June, 2017 No routine f u visit required assess the following at other routine visits 4 nbsp nbsp satisfaction concerns w method nbsp nbsp health status changes nbsp nbsp BP nbsp nbsp weight changes
By vgreene, 2 June, 2017 Back up contraception abstinence required x7 days after initiation in certain situations Use barrier method or abstain x7 days if nbsp nbsp initiated 5 days after start of menses3 nbsp nbsp amenorrheic not post partum 3 nbsp nbsp 21 days post partum and m
By vgreene, 2 June, 2017 Counsel about potential changes in bleeding patterns 3 nbsp nbsp Spotting light bleeding common during first 3 6mo Generally not harmful and may darr w continued use nbsp nbsp If clinically indicated consider factors such as inconsistent use interaction s
By vgreene, 2 June, 2017 If pt healthy few exams tests required before initiation 3 nbsp nbsp Measure BP before initiation 4 nbsp nbsp Consider baseline weight BMI 4 nbsp nbsp Pts w known medical conditions may need additional exams tests to determine if candidate for this method
